BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 27501342)

  • 1. Activatable molecular MRI nanoprobe for tumor cell imaging based on gadolinium oxide and iron oxide nanoparticle.
    Li J; Wang S; Wu C; Dai Y; Hou P; Han C; Xu K
    Biosens Bioelectron; 2016 Dec; 86():1047-1053. PubMed ID: 27501342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T
    Li J; You J; Wu C; Dai Y; Shi M; Dong L; Xu K
    Int J Nanomedicine; 2018; 13():4607-4625. PubMed ID: 30127609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gadolinium oxide nanoparticles and aptamer-functionalized silver nanoclusters-based multimodal molecular imaging nanoprobe for optical/magnetic resonance cancer cell imaging.
    Li J; You J; Dai Y; Shi M; Han C; Xu K
    Anal Chem; 2014 Nov; 86(22):11306-11. PubMed ID: 25338209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadolinium-encapsulating iron oxide nanoprobe as activatable NMR/MRI contrast agent.
    Santra S; Jativa SD; Kaittanis C; Normand G; Grimm J; Perez JM
    ACS Nano; 2012 Aug; 6(8):7281-94. PubMed ID: 22809405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving sensitivity of magnetic resonance imaging by using a dual-targeted magnetic iron oxide nanoprobe.
    Chen L; Xie J; Wu H; Zang F; Ma M; Hua Z; Gu N; Zhang Y
    Colloids Surf B Biointerfaces; 2018 Jan; 161():339-346. PubMed ID: 29100127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-pot preparation of hydrophilic manganese oxide nanoparticles as T
    Li J; Wu C; Hou P; Zhang M; Xu K
    Biosens Bioelectron; 2018 Apr; 102():1-8. PubMed ID: 29101783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-specific design of PEGylated gadolinium-based nanoscale particles: Facile synthesis, characterization, and improved magnetic resonance imaging of metastasis lung cancer.
    Sui Y; Li Y; Li Y; Jin H; Zheng Y; Huang W; Chen S
    J Photochem Photobiol B; 2020 Jan; 202():111669. PubMed ID: 31739258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gadolinium-doped carbon quantum dots loaded magnetite nanoparticles as a bimodal nanoprobe for both fluorescence and magnetic resonance imaging.
    Huang Y; Li L; Zhang D; Gan L; Zhao P; Zhang Y; Zhang Q; Hua M; Jia C
    Magn Reson Imaging; 2020 May; 68():113-120. PubMed ID: 32032662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fe
    Wang C; Yan C; An L; Zhao H; Song S; Yang S
    J Mater Chem B; 2021 Sep; 9(37):7734-7740. PubMed ID: 34586149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrin-releasing peptide receptor-targeted gadolinium oxide-based multifunctional nanoparticles for dual magnetic resonance/fluorescent molecular imaging of prostate cancer.
    Cui D; Lu X; Yan C; Liu X; Hou M; Xia Q; Xu Y; Liu R
    Int J Nanomedicine; 2017; 12():6787-6797. PubMed ID: 28979118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Encapsulation of Gadolinium Oxide Nanoparticle (Gd
    Mekuria SL; Debele TA; Tsai HC
    ACS Appl Mater Interfaces; 2017 Mar; 9(8):6782-6795. PubMed ID: 28164704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Labeling of cancer cells with magnetic nanoparticles for magnetic resonance imaging.
    Weis C; Blank F; West A; Black G; Woodward RC; Carroll MR; Mainka A; Kartmann R; Brandl A; Bruns H; Hallam E; Shaw J; Murphy J; Teoh WY; Aifantis KE; Amal R; House M; Pierre TS; Fabry B
    Magn Reson Med; 2014 May; 71(5):1896-905. PubMed ID: 23813415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-resolution cellular MRI: gadolinium and iron oxide nanoparticles for in-depth dual-cell imaging of engineered tissue constructs.
    Di Corato R; Gazeau F; Le Visage C; Fayol D; Levitz P; Lux F; Letourneur D; Luciani N; Tillement O; Wilhelm C
    ACS Nano; 2013 Sep; 7(9):7500-12. PubMed ID: 23924160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and characterization of PEGylated Gd2O3 nanoparticles for MRI contrast enhancement.
    Ahrén M; Selegård L; Klasson A; Söderlind F; Abrikossova N; Skoglund C; Bengtsson T; Engström M; Käll PO; Uvdal K
    Langmuir; 2010 Apr; 26(8):5753-62. PubMed ID: 20334417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tunable T1 and T2 contrast abilities of manganese-engineered iron oxide nanoparticles through size control.
    Huang G; Li H; Chen J; Zhao Z; Yang L; Chi X; Chen Z; Wang X; Gao J
    Nanoscale; 2014 Sep; 6(17):10404-12. PubMed ID: 25079966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gadolinium (III) oxide nanoparticles coated with folic acid-functionalized poly(β-cyclodextrin-co-pentetic acid) as a biocompatible targeted nano-contrast agent for cancer diagnostic: in vitro and in vivo studies.
    Mortezazadeh T; Gholibegloo E; Alam NR; Dehghani S; Haghgoo S; Ghanaati H; Khoobi M
    MAGMA; 2019 Aug; 32(4):487-500. PubMed ID: 30730021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RGD-functionalized ultrasmall iron oxide nanoparticles for targeted T₁-weighted MR imaging of gliomas.
    Luo Y; Yang J; Yan Y; Li J; Shen M; Zhang G; Mignani S; Shi X
    Nanoscale; 2015 Sep; 7(34):14538-46. PubMed ID: 26260703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuning the relaxation rates of dual-mode T(1)/T(2) nanoparticle contrast agents: a study into the ideal system.
    Keasberry NA; Bañobre-López M; Wood C; Stasiuk GJ; Gallo J; Long NJ
    Nanoscale; 2015 Oct; 7(38):16119-28. PubMed ID: 26371437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic targeting combined with active targeting of dual-ligand iron oxide nanoprobes to promote the penetration depth in tumors for effective magnetic resonance imaging and hyperthermia.
    Chen L; Wu Y; Wu H; Li J; Xie J; Zang F; Ma M; Gu N; Zhang Y
    Acta Biomater; 2019 Sep; 96():491-504. PubMed ID: 31302299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Holographically Activatable Nanoprobe via Glutathione/Albumin-Mediated Exponential Signal Amplification for High-Contrast Tumor Imaging.
    Li T; Tan S; Li M; Luo J; Zhang Y; Jiang Z; Deng Y; Han L; Ke H; Shen J; Tang Y; Liu F; Chen H; Yang T
    Adv Mater; 2023 Mar; 35(10):e2209603. PubMed ID: 36524741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.